Cargando…
Sensitive GATA1 mutation screening reliably identifies neonates with Down syndrome at risk for myeloid leukemia
Autores principales: | Goemans, Bianca F., Noort, Sanne, Blink, Marjolein, Wang, Yong-Dong, Peters, Susan T. C. J., van Wouwe, Jacobus P., Kaspers, Gertjan, de Haas, Valerie, Kollen, Wouter J., van der Velden, Vincent H. J., Gruber, Tanja A., Zwaan, Christian M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8324475/ https://www.ncbi.nlm.nih.gov/pubmed/33483616 http://dx.doi.org/10.1038/s41375-021-01128-1 |
Ejemplares similares
-
Treating CD33-Positive de novo Acute Myeloid Leukemia in Pediatric Patients: Focus on the Clinical Value of Gemtuzumab Ozogamicin
por: Wijnen, Noa E, et al.
Publicado: (2023) -
Increased survival disparities among children and adolescents & young adults with acute myeloid leukemia: A Dutch population‐based study
por: Schulpen, Maya, et al.
Publicado: (2021) -
Effect of Antibacterial Prophylaxis on Febrile Neutropenic Episodes and Bacterial Bloodstream Infections in Dutch Pediatric Patients with Acute Myeloid Leukemia: A Two-Center Retrospective Study
por: Van Weelderen, Romy E., et al.
Publicado: (2022) -
Clinical outcomes of second relapsed and refractory first relapsed paediatric AML: A retrospective study within the NOPHO‐DB SHIP consortium
por: White, Tara, et al.
Publicado: (2022) -
Healthy Growth in Children with Down Syndrome
por: Van Gameren-Oosterom, Helma B. M., et al.
Publicado: (2012)